|

Prograf (SOC) Clinical Trials

1 actively recruiting trial

Pipeline

Phase 4: 1

Top Sponsors

  • University of Alberta1

Indications

  • Immunosuppressant Adverse Reaction1
  • Renal Insufficiency1
  • Liver Disease1
  • Liver Transplant; Complications1
  • Cardiovascular Diseases1

Other1 trial

Extended-Release Tacrolimus Following Liver Transplantation
Phase 4

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.